Their study, presented at ENDO 2026, the annual meeting of the Endocrine Society, found that adults taking multiple blood pressure medicines experienced a small but significant increase in hypotension-related events after starting a GLP-1 receptor agonist
Routine testosterone monitoring is not necessary for all patients on semaglutide
some people might share their transformation because they arent happy with the change and want to raise awareness
At present, the effects of incretin combination therapies on weight loss are approaching those of bariatric surgery, marking the advent of a new era in pharmacological treatment for obesity
While more research is still needed, the potential benefits extend far beyond the scale
The available data on the use of edoxaban for VTE treatment in obese populations are limited, and apixaban or rivaroxaban is more appropriate for this population